Auxly Cannabis Group Stock Forecast, Price & News

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Auxly Cannabis Group in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Auxly Cannabis Group stock.
View analyst ratings for Auxly Cannabis Group or view top-rated stocks.

Wall Street analysts have given Auxly Cannabis Group a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Auxly Cannabis Group wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Auxly Cannabis Group is scheduled to release its next quarterly earnings announcement on Friday, August 27th 2021.
View our earnings forecast for Auxly Cannabis Group.

Auxly Cannabis Group Inc. (OTCMKTS:CBWTF) released its earnings results on Friday, May, 28th. The company reported ($0.01) earnings per share (EPS) for the quarter. The company had revenue of $7.90 million for the quarter. Auxly Cannabis Group had a negative trailing twelve-month return on equity of 38.03% and a negative net margin of 161.57%.
View Auxly Cannabis Group's earnings history.

Auxly Cannabis Group's stock was trading at $0.2830 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, CBWTF stock has decreased by 28.3% and is now trading at $0.2028.
View which stocks have been most impacted by COVID-19.

3 Wall Street analysts have issued 12-month price objectives for Auxly Cannabis Group's stock. Their forecasts range from $0.40 to $0.60. On average, they anticipate Auxly Cannabis Group's share price to reach $0.50 in the next year. This suggests a possible upside of 146.5% from the stock's current price.
View analysts' price targets for Auxly Cannabis Group or view top-rated stocks among Wall Street analysts.

Some companies that are related to Auxly Cannabis Group include Inotiv (NOTV), Starpharma (SPHRY), Luna Innovations (LUNA), CM Life Sciences II (CMII), Inhibitor Therapeutics (INTI), HedgePath Pharmaceuticals (HPPI), AIkido Pharma (AIKI), AIkido Pharma (AIKI), Bioqual (BIOQ), Eloxx Pharmaceuticals (ELOX), ProMIS Neurosciences (ARFXF), iSpecimen (ISPC), Vitality Biopharma (VBIO), U.S. Stem Cell (USRM) and Protalex (PRTX).
View all of CBWTF's competitors.

Auxly Cannabis Group trades on the OTCMKTS under the ticker symbol "CBWTF."

Shares of CBWTF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CBWTF stock can currently be purchased for approximately $0.20.

Auxly Cannabis Group has a market capitalization of $168.81 million and generates $37.92 million in revenue each year.

Auxly Cannabis Group employs 431 workers across the globe.

The official website for Auxly Cannabis Group is www.auxly.com.

Auxly Cannabis Group is headquartered at 777 Richmond St W Unit 002, Toronto A6, M6J 0C2.

Auxly Cannabis Group's mailing address is 777 Richmond St W Unit 002, Toronto A6, M6J 0C2. The company can be reached via phone at (647) 812-0121 or via email at [email protected]